Rafferty Asset Management, LLC Gilead Sciences, Inc. Transaction History

Rafferty Asset Management, LLC

$26.8 Billion
Q2 2024

A detailed history of Rafferty Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 596,197 shares of GILD stock, worth $52.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

596,197

Previous 419,678 42.06%

Holding current value

$52.5 Million

Previous $30.7 Million 33.06%

% of portfolio

0.15%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $11.1 Million - $12.9 Million	176,519 Added 42.06%	596,197 $40.9 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $3.19 Million - $3.89 Million	44,530 Added 11.87%	419,678 $30.7 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $1.22 Million - $1.38 Million	16,626 Added 4.64%	375,148 $30.4 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $3.04 Million - $3.31 Million	41,064 Added 12.94%	358,522 $26.9 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $4.02 Million - $4.59 Million	52,935 Added 20.01%	317,458 $24.5 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $1.05 Million - $1.2 Million	13,576 Added 5.41%	264,523 $21.9 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $1.55 Million - $2.23 Million	-24,915 Reduced 9.03%	250,947 $21.5 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $4.3 Million - $4.92 Million	72,281 Added 35.5%	275,862 $17 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $2.21 Million - $2.48 Million	-38,206 Reduced 15.8%	203,581 $12.6 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $3.91 Million - $4.9 Million	67,505 Added 38.73%	241,787 $14.4 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $2.05 Million - $2.33 Million	31,602 Added 22.15%	174,282 $12.7 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $1.49 Million - $1.61 Million	21,980 Added 18.21%	142,680 $9.97 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $922,472 - $1.01 Million	-14,534 Reduced 10.75%	120,700 $8.31 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $1.99 Million - $2.27 Million	33,187 Added 32.52%	135,234 $8.74 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $155,617 - $177,318	2,747 Added 2.77%	102,047 $5.95 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $1.14 Million - $1.44 Million	18,409 Added 22.76%	99,300 $6.28 Million
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $1.63 Million - $1.89 Million	22,544 Added 38.64%	80,891 $6.22 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $4.46 Million - $5.72 Million	-71,270 Reduced 54.99%	58,347 $4.36 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $132,852 - $146,133	-2,156 Reduced 1.64%	129,617 $8.42 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $1.9 Million - $2.1 Million	-30,365 Reduced 18.73%	131,773 $8.35 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $3.13 Million - $3.51 Million	50,523 Added 45.27%	162,138 $11 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $5.36 Million - $6 Million	85,682 Added 330.4%	111,615 $7.26 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $111,514 - $145,518	-1,842 Reduced 6.63%	25,933 $1.62 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $99,649 - $110,330	1,398 Added 5.3%	27,775 $2.15 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $391,485 - $456,653	6,034 Added 29.66%	26,377 $1.87 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $38,678 - $47,152	531 Added 2.68%	20,343 $1.53 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $58,912 - $69,154	828 Added 4.36%	19,812 $1.42 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1.37 Million - $1.62 Million	18,984	18,984 $1.54 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Gilead Sciences, Inc. Transaction History